TY - JOUR
T1 - Reconduction after second-generation cryoballoon-based pulmonary vein isolation ― impact of different ablation strategies ―
AU - Heeger, Christian Hendrik
AU - Rexha, Enida
AU - Maack, Sabrina
AU - Rottner, Laura
AU - Fink, Thomas
AU - Mathew, Shibu
AU - Maurer, Tilman
AU - Lemeš, Christine
AU - Rillig, Andreas
AU - Wohlmuth, Peter
AU - Reissmann, Bruno
AU - Tilz, Roland Richard
AU - Ouyang, Feifan
AU - Kuck, Karl Heinz
AU - Metzner, Andreas
N1 - Funding Information:
C.-H.H. received travel grants and research grants by Medtronic, Claret Medical, SentreHeart, Boston, Pfizer, Biosense Webster and Cardiofocus. K.-H.K. received travel grants and research grants from Biosense Webster, Stereotaxis, Prorhythm, Medtronic, Edwards, Cryocath, and is a consultant to St. Jude Medical, Biosense Webster, Prorhythm, and Stereotaxis. He received speaker’s honoraria from Medtronic. R.R.T. received travel grants from St. Jude Medical, Topera, Biosense Webster, Daiichi Sankyo, SentreHeart and Speaker’s Bureau Honoraria from Biosense Webster, Biotronik, Pfizer, Topera, Bristol-Myers Squibb; Bayer, Sano Aventis and research grants by Cardiofocus. A.M. received speaker’s honoraria and travel grants from Medtronic, Biosense Webster and Cardiofocus. All other authors have no conflicts of interest to declare.
Publisher Copyright:
© 2020 Japanese Circulation Society. All rights reserved.
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/5/25
Y1 - 2020/5/25
N2 - Background: The second-generation cryoballoon (CB2) has demonstrated high procedural efficacy and convincing clinical success rates for pulmonary vein isolation (PVI). Nevertheless, data on the impact of different ablations protocols on durability are limited. The aim was to comparing the durability of PVI following 3 different ablation strategies in patients with recurrence of atrial fibrillation or atrial tachycardia undergoing repeat procedures. Methods and Results: In 192 patients, a total of 751 PVs were identified. All PVs were successfully isolated during index PVI. Thirty-one out of 192 (16%) patients were treated with a bonus-freeze protocol (group 1), 67/192 (35%) patients with a no bonus-freeze protocol (group 2), and 94/192 (49%) patients with a time-to-effect-guided protocol (group 3). Persistent PVI was documented in 419/751 (55.8%) PVs, and in 41/192 (21%) patients, all PVs were persistently isolated. The total rate of PV reconnection was not significantly different between the groups (P=0.134) and the comparison of individual PVs revealed no differences (P-values for RSPV: 0.424, RIPV: 0.541, LSPV: 0.788, LIPV: 0.346, LCPV: 0.865). The procedure times were significantly reduced by omitting the bonus-freeze and applying individualized application times (group 1: 123.4±31.5 min, group 2: 112.9±39.8 min, group 3: 86.67±28.4 min, P<0.001). Conclusions: Comparing 3 common ablation protocols, no differences for durable PVI were detected. Procedure times were significantly reduced by omitting the bonus-freeze cycle and by applying individualized application times.
AB - Background: The second-generation cryoballoon (CB2) has demonstrated high procedural efficacy and convincing clinical success rates for pulmonary vein isolation (PVI). Nevertheless, data on the impact of different ablations protocols on durability are limited. The aim was to comparing the durability of PVI following 3 different ablation strategies in patients with recurrence of atrial fibrillation or atrial tachycardia undergoing repeat procedures. Methods and Results: In 192 patients, a total of 751 PVs were identified. All PVs were successfully isolated during index PVI. Thirty-one out of 192 (16%) patients were treated with a bonus-freeze protocol (group 1), 67/192 (35%) patients with a no bonus-freeze protocol (group 2), and 94/192 (49%) patients with a time-to-effect-guided protocol (group 3). Persistent PVI was documented in 419/751 (55.8%) PVs, and in 41/192 (21%) patients, all PVs were persistently isolated. The total rate of PV reconnection was not significantly different between the groups (P=0.134) and the comparison of individual PVs revealed no differences (P-values for RSPV: 0.424, RIPV: 0.541, LSPV: 0.788, LIPV: 0.346, LCPV: 0.865). The procedure times were significantly reduced by omitting the bonus-freeze and applying individualized application times (group 1: 123.4±31.5 min, group 2: 112.9±39.8 min, group 3: 86.67±28.4 min, P<0.001). Conclusions: Comparing 3 common ablation protocols, no differences for durable PVI were detected. Procedure times were significantly reduced by omitting the bonus-freeze cycle and by applying individualized application times.
UR - http://www.scopus.com/inward/record.url?scp=85085531955&partnerID=8YFLogxK
U2 - 10.1253/circj.CJ-19-1144
DO - 10.1253/circj.CJ-19-1144
M3 - Journal articles
C2 - 32307357
AN - SCOPUS:85085531955
SN - 1346-9843
VL - 84
SP - 902
EP - 910
JO - Circulation Journal
JF - Circulation Journal
IS - 6
ER -